248 filings
Page 3 of 13
8-K
8e6u7azk a2fl
3 Jun 22
CytoSorbents Partners with Nikkiso to Distribute the PureADJUST Hemoperfusion Blood Pump and Supplies in 14 Countries
4:15pm
8-K
6sx4n9bs180 4jc
31 May 22
Other Events
5:48pm
8-K
ntucq8qt
3 May 22
CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook
7:04pm
8-K
5jy7265 wxas178nzpm
29 Apr 22
Other Events
4:31pm
8-K
izx lxuxr
28 Apr 22
CytoSorbents Highlights the Strategy of “Enhanced Lung Rest” Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress
5:00pm
8-K
jhqfiknbwlgjzca4tvk
14 Apr 22
CytoSorbents To Expand Direct Sales of CytoSorb® to the United Kingdom, the Sixth Largest Medical Device Market in the World
4:15pm
8-K
ppqhxrzp2kq
7 Apr 22
CytoSorbents Receives Approximately $740,000 from the New Jersey Business Tax Certificate Transfer Program
4:30pm
8-K
x3okqxd a2dun
5 Apr 22
CytoSorbents Appoints Jiny Kim, MBA to its Board of Directors
4:30pm
8-K
7dgjxbc
17 Mar 22
Other Events
4:31pm
8-K
sb41r
8 Mar 22
CytoSorbents Reports Fourth Quarter and Full Year 2021 Results and 2021 total revenue was $43.2 million, including product sales of $40.1 million. Core
5:15pm
8-K
k4j hwj5l
1 Feb 22
Other Events
4:31pm
8-K
14cswxv15q b9o
24 Jan 22
Other Events
4:30pm
8-K
1iqxnee7nupl3arefjqa
20 Jan 22
Entry into a Material Definitive Agreement
4:30pm
8-K
ikfw8vjue14mvn
18 Jan 22
CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2021 Revenue
4:30pm
8-K
1lji3 wv1e76ufdvy
30 Dec 21
Entry into a Material Definitive Agreement
5:28pm
8-K
3ux0yjgl9mzk2ogtb0ad
21 Dec 21
Other Events
9:00am
8-K
llpuodvpwaq rxtgd7yp
4 Nov 21
CytoSorbents Reports Full Third Quarter 2021 Financial and Third Quarter 2021 total revenue was $9.8 million, including product sales of $8.9
4:49pm
8-K
39phwlkx5c2
21 Oct 21
CytoSorbents Comments on REMOVE Study Presentation
6:01am
8-K
ovc6lzxgi2ns6f6
15 Oct 21
Other Events
12:00am
8-K
i43mw
13 Oct 21
CytoSorbents Provides Preliminary Third Quarter Business Update and Revised 2021 Product Revenue Guidance
7:00am